Key result
Non-ischemic cardiogenic shock surpasses AMI-related shock in incidence across some populations while carrying high mortality.
Why the study?
Non-ischemic cardiogenic shock is an important cause of shock with increasing incidence and high mortality, exceeding that of AMI-related shock in some populations.
How can early recognition and distinctive management improve outcomes in non-ischemic cardiogenic shock?
How can early recognition and distinctive management improve outcomes in non-ischemic cardiogenic shock?
This review highlights the increasing incidence of non-ischemic cardiogenic shock and discusses strategies for early recognition and management to improve outcomes.
Non-ischemic cardiogenic shock may predominate in emergency settings; leaves open optimal risk stratification and therapies pending higher-level evidence.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Hastenteufel et al. (2024) conducted a review in Non-Ischemic Cardiogenic Shock. Non-ischemic cardiogenic shock is an increasingly recognized condition with an incidence exceeding that of AMI-related shock in some populations and a high mortality rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: